(EMAILWIRE.COM, February 02, 2019 ) The dental biomaterials market is segmented into implantology, prosthodontics, orthodontics, and other applications. The orthodontics application segment is expected to grow at the highest CAGR during the forecast period. Dental Biomaterials Market – Key Players, Share, Overview, Industry Insights, Top Trends Drives the Growth by 7.4% CAGR and Worth Reach US$ 9.6 Billion by 2023
Get the Free PDF Brochure Now at
http://www.reportsnreports.com/contacts/requestsample.aspx?name=1853230
.
The global dental biomaterials market is projected to reach USD 9.6 billion by 2023, from USD 6.7 billion in 2018 growing at a CAGR of7.4% from 2018 to 2023. Factors such as the increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market.
The prominent players in the global dental biomaterials market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
Geographically, the global dental biomaterial market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and growing number of dental hospitals and clinics.
Click Here for More Details Now at
http://www.openpr.com/news/1512489/Dental-Biomaterials-Market-Key-Players-Share-Overview-Industry-Insights-Top-Trends-Drives-the-Growth-by-7-4-CAGR-and-Worth-Reach-US-9-6-Billion-by-2023.html .
The high growth of this segment is driven by technological advancements in orthodontic brackets (such as self-ligating brackets), the presence of a large patient base with malocclusions, and the increasing incidence of jaw diseases are the key factors driving the growth of this market.
Recent Developments
1. In 2018, The Straumann Group acquired a 30% stake in its biomaterials partner, Botiss medical AG, for an undisclosed sum. This acquisition enables Straumann to expand its dental biomaterials portfolio.
2. In 2018, Henry Schein, Inc. acquired Intra-Lock (Spain), a provider of dental restoration solutions. This will enhance its position in the premium implant segment
3. In 2018, Carpenter Technology Corporation announced the expansion of its Emerging Technology Center in the Alabama Campus (US).
4. In 2017, Geistlich Pharma opened its tenth subsidiary in India. This marked Geistlichs entry into a potentially interesting market for regenerative dentistry.
Place the Order on Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User – Global Forecast to 2023 at http://www.reportsnreports.com/purchase.aspx?name=1853230 .
The company is expected to grow further in the coming years due to its increasing focus on countries such as China, India, Argentina, Chile, and Colombia. Straumann significantly invests in R&D, sales, and marketing activities to drive innovation and to capture the growth potential in underpenetrated markets. In order to increase its customer base and maintain its position in the market, the company focuses on various growth strategies such as acquisitions, agreements, and product launches.
Break of primary participants was as mentioned below:
By Company Type Tier 131%, Tier 245% and Tier 324%
By Designation C-level24%, Director Level47%, Others29%
By Region North America34%, Europe32%, Asia-Pacific16%, Latin America10%,Middle East & Africa8%
Snehal
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
